Drug Trial Radar · NCT04402489
Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked Protoporphyria
Last checked: Nov 20, 2026Latest source record: Dec 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
184
Actual
Start
Jun 1, 2020
Primary completion
Dec 14, 2021
Study completion Jul 26, 2022
Sponsor
- Lead sponsor
- Tanabe Pharma America, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 26, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to investigate the efficacy of MT-7117 on time to onset and severity of first prodromal symptoms (burning, tingling, itching, or stinging) associated with sunlight exposure in adults and adolescents with EPP or XLP aged 12-75.
Conditions
- EPP
- XLP
Interventions
PlaceboDrug
Placebo
MT-7117 Low DoseDrug
MT-7117 Low Dose
MT-7117 High DoseDrug
MT-7117 High Dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Average Daily Sunlight Exposure Time (Minutes) to First Prodromal Symptom (Burning, Tingling, Itching, or Stinging) Associated With Sunlight Exposure Between 1 Hour Post Sunrise and 1 Hour Pre-sunset at Week 26 (Visit 7)Time frame: From 1 hour post-sunrise to 1 hour pre-sunset at Week 26 (Visit 7)
Locations
31 sites in 10 countries. Site status is shown where the registry gives one.
Marvel Clinical Research, LLC
Huntington Beach, California
University Of Miami School Of Medicine, Center For Liver Diseases
Miami, Florida
MetroBoston Clinical Partners, LLC
Brighton, Massachusetts
Kansas City Research Institute
Kansas City, Missouri
Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH)
New York, New York
Wake Forest University Baptist Health
Winston-Salem, North Carolina
Remington-Davis Clinical Research
Columbus, Ohio
Thomas Jefferson University
Philadelphia, Pennsylvania
The University of Texas Medical Branch (UTMB)
Galveston, Texas
University of Washington-Seattle Cancer Care Alliance
Seattle, Washington
The Wesley Hospital
Brisbane, Queensland, Australia
Royal Melbourne Hospital (RMH)
Melbourne, Victoria, Australia
University of Alberta
Edmonton, Alberta, Canada
Charite - Universitaetsmedizin Berlin
Berlin, Germany
Westfaelische Wilhelms-Universitaet Muenster
Münster, Northrhein Westalien, Germany
Azienda Ospedaliera Spedali Civili di Brescia-Universita degli Studi Di Brescia
Brescia, Italy
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano
Milan, Italy
U.O.C. Medicina Interna Azienda ospedaliero Universitaria Policlinico di Modena
Modena, Italy
I.F.O Hospital Centro Porfirie e Malattie Rare
Rome, Italy
Kobe University Hospital
Kobe, Hyōgo, Japan
Sophia Dermatology Clinic
Kanazawa, Ishikawa-ken, Japan
Investigator site
Sayama, Osaka, Japan
Osaka Medical College Hospital
Takatsuki, Osaka, Japan
Tokyo Saiseikai Central Hospital
Minato-ku, Tokyo, Japan
Toyama University Hospital
Sugitani, Toyama, Japan
Haukeland University Hospital
Bergen, Norway
Hospital Clínic de Barcelona
Barcelona, Spain
Hospital Universitario 12 de Octubre
Madrid, Spain
Karolinska University Hospital
Stockholm, Sweden
Evelina London Children's Hospital - Guy's & St Thomas' NHS Foundation Trust
London, United Kingdom
University of Manchester
Salford, Manchester, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.